These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 13109525)

  • 1. Studies in the therapy of parkinsonism: Panparnit.
    EFFRON AS
    J Nerv Ment Dis; 1953 Jul; 118(1):72-5. PubMed ID: 13109525
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Parkinsonism.
    GILLHESPY RO; BALESTRIERI A; SIGNORATO U
    Br Med J; 1958 Jun; 1(5086):1542. PubMed ID: 13546622
    [No Abstract]   [Full Text] [Related]  

  • 3. Kemadrin in the treatment of parkinsonism.
    SCHWAB RS; CHAFETZ ME
    Neurology; 1955 Apr; 5(4):273-7. PubMed ID: 14370378
    [No Abstract]   [Full Text] [Related]  

  • 4. Trial of a new remedy (Ciba 10870) in Parkinsonism.
    HUGHES W; KEEVIL JH; GIBBS IE
    Br Med J; 1958 Apr; 1(5076):928-9. PubMed ID: 13523232
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of pagitane hydrochloride in parkinsonism.
    DOW RS; SMITH GN
    Neurology; 1954 Jan; 4(1):33-9. PubMed ID: 13133049
    [No Abstract]   [Full Text] [Related]  

  • 6. [New methods of medicinal treatment of extrapyramidal disorders, with special reference to parkinsonism & postencephalitic parkinsonism].
    RUTHER W; THEISS W
    Med Klin; 1958 Aug; 53(35):1495-7. PubMed ID: 13589544
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of benzotropine sulfonate in the treatment of parkinsonism.
    O'DOHERTY D; FORSTER FM
    Med Ann Dist Columbia; 1953 May; 22(5):221-3. PubMed ID: 13045920
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of parkinsonism with pagitane hydrochloride; results in 142 patients.
    ZIER A; DOSHAY LJ
    Neurology; 1954 Sep; 4(9):682-9. PubMed ID: 13214268
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of a new agent in the treatment of parkinsonism.
    MULDER DW
    Proc Staff Meet Mayo Clin; 1953 Apr; 28(7):210-6. PubMed ID: 13056003
    [No Abstract]   [Full Text] [Related]  

  • 10. Parkinsonism: treatment with curare.
    BERGER H
    Ann Intern Med; 1956 Nov; 45(5):946-50. PubMed ID: 13373192
    [No Abstract]   [Full Text] [Related]  

  • 11. Parkinsonism: preliminary report on two new antiparkinsonian agents.
    BERRIS H
    J Lancet; 1954 Jul; 74(7):245-6; passim. PubMed ID: 13221950
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of parkinsonism with a new antispasmodic compound.
    MAGEE KR; DEJONG RN
    Med Bull (Ann Arbor); 1953 Mar; 19(3):59-61. PubMed ID: 13049719
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of the effectiveness of drug therapy in parkinsonism.
    KAPLAN HA; MACHOVER S; RABINER A
    J Nerv Ment Dis; 1954 May; 119(5):398-411. PubMed ID: 13192483
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myographic and clinical observations on two new antihistaminics used in the treatment of parkinsonism].
    STEGER R; HUFSCHMIDT HJ
    Dtsch Z Nervenheilkd; 1958; 178(4):413-30. PubMed ID: 13609390
    [No Abstract]   [Full Text] [Related]  

  • 15. Preliminary study of a new anti-parkinson agent.
    DOSHAY LJ; CONSTABLE K; FROMER S
    Neurology; 1952; 2(3):233-43. PubMed ID: 14929300
    [No Abstract]   [Full Text] [Related]  

  • 16. Kemadrin, a new drug for treatment of Parkinsonian disease.
    LERNER PF
    J Nerv Ment Dis; 1956 Jan; 123(1):79-82. PubMed ID: 13346366
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trials of transergan in the parkinsonian syndrome.
    ELIASSON S; TEJNING S
    Acta Med Scand; 1956 Jun; 154(5):375-9. PubMed ID: 13326279
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of combined therapy of parkinsonian conditions, especially postencephalitic conditions].
    KIRCHHOF JK
    Nervenarzt; 1956 Oct; 27(10):447-53. PubMed ID: 13387960
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic activity of a new drug, M.G. 1229, 4-(gamma-diethylaminopropyl)-hydroxydiphenylethane, in the parkinsonian syndrome].
    DONATI A; MORI G
    Gazz Med Ital; 1956 Oct; 115(10):331-4. PubMed ID: 13384655
    [No Abstract]   [Full Text] [Related]  

  • 20. Parkinsonism: drug therapy; neurosurgical therapy.
    O'DOHERTY DS; COOPER IS
    Postgrad Med; 1958 Dec; 24(6):681-6. PubMed ID: 13614064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.